Loading...

Sonic Healthcare Limited

SKHHYPNK
HealthcareMedical - Diagnostics & Research
$17.28
$-0.08(-0.46%)

Sonic Healthcare Limited (SKHHY) Stock Overview

Explore Sonic Healthcare Limited’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
12.17%
12.17%
Profit Growth
$1.07
25.39%
EPS Growth
$1.07
26.71%
Operating Margin
6.27%
0.47%
ROE
6.54%
25.39%
Dividend Yield
0.00%
2.59%

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0

Price Targets

Low$28.10
Average$30.15
High$32.20

Company Profile

Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners. The company operates in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

CEO

Dr. Colin Stephen Goldschmidt F.A.C.I.D., F.A.I.C.D., F.R.C.P.A., M.B.B.Ch.

Employees

42,000

Headquarters

Grosvenor Place, Sydney, NSW

Founded

2010

Frequently Asked Questions